| Date Filed | Type | Description |
| 07/21/2023 |
4/A
| Form 4/A - Statement of changes in beneficial ownership of securities: [Amend] |
| 07/17/2023 |
4
| Henderson Molly (CFO and CBO) has filed a Form 4 on Phathom Pharmaceuticals, Inc.|
Txns:
| Granted 25,000 shares
@ $1, valued at
$25k
|
|
| 06/05/2023 |
4
| Henderson Molly (CFO and CBO) has filed a Form 4 on Phathom Pharmaceuticals, Inc.|
Txns:
| Sold 1,960 shares
@ $11.4121, valued at
$22.4k
|
|
| 05/23/2023 |
4
| Henderson Molly (CFO and CBO) has filed a Form 4 on Phathom Pharmaceuticals, Inc.|
Txns:
| Sold 2,110 shares
@ $12.8744, valued at
$27.2k
|
|
| 03/03/2023 |
4
| Henderson Molly (CFO and CBO) has filed a Form 4 on Phathom Pharmaceuticals, Inc.|
Txns:
| Sold 2,032 shares
@ $8.5309, valued at
$17.3k
|
|
| 01/20/2023 |
4
| Henderson Molly (CFO and CBO) has filed a Form 4 on Phathom Pharmaceuticals, Inc.|
Txns:
| Granted 33,000 shares
@ $0
Granted 55,000 options to buy
@ $8.35, valued at
$459.3k
|
|
| 11/23/2022 |
4
| Henderson Molly (CFO and CBO) has filed a Form 4 on Phathom Pharmaceuticals, Inc.|
Txns:
| Sold 2,159 shares
@ $9.6, valued at
$20.7k
|
|
| 09/02/2022 |
4
| Henderson Molly (CFO and CBO) has filed a Form 4 on Phathom Pharmaceuticals, Inc.|
Txns:
| Granted 7,500 shares
@ $0 |
|
| 05/20/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/16/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 04/06/2022 |
4
| Henderson Molly (CFO and CBO) has filed a Form 4 on Phathom Pharmaceuticals, Inc.|
Txns:
| Granted 20,000 shares
@ $0
Granted 100,000 options to buy
@ $15.08, valued at
$1.5M
|
|
| 04/06/2022 |
3
| Henderson Molly (CFO and CBO) has filed a Form 3 on Phathom Pharmaceuticals, Inc. |
| 02/02/2022 |
4
| Henderson Molly (CFO) has filed a Form 4 on UroGen Pharma Ltd.|
Txns:
| Sold 331 shares
@ $7.58, valued at
$2.5k
Exercised 666 restricted stock units
@ $0
Granted 7,500 restricted stock units
@ $0
Granted 30,000 options to buy
@ $7.72, valued at
$231.6k
|
|
| 12/02/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/08/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/18/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/02/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 10/05/2020 |
4
| Henderson Molly (CFO) has filed a Form 4 on UroGen Pharma Ltd.|
Txns:
| Granted 60,000 options to buy
@ $19.66, valued at
$1.2M
Granted 15,000 restricted stock units
@ $0 |
|
| 10/05/2020 |
3
| Henderson Molly (CFO) has filed a Form 3 on UroGen Pharma Ltd. |
| 05/05/2020 |
4
| Henderson Molly (Executive Vice President & CFO) has filed a Form 4 on Advaxis, Inc.|
Txns:
| Granted 50,000 options
@ $0.66, valued at
$33k
|
|
| 10/25/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 04/11/2019 |
4
| Henderson Molly (Executive Vice President & CFO) has filed a Form 4 on Advaxis, Inc.|
Txns:
| Granted 2,500 shares
@ $3.6799, valued at
$9.2k
|
|
| 04/10/2019 |
4
| Henderson Molly (Executive Vice President & CFO) has filed a Form 4 on Advaxis, Inc.|
Txns:
| Granted 2,900 shares
@ $3.8599, valued at
$11.2k
Granted 100 shares
@ $3.85, valued at
$385 |
|
| 11/07/2018 |
4
| Henderson Molly (Executive Vice President & CFO) has filed a Form 4 on Advaxis, Inc.|
Txns:
| Granted 125,000 options
@ $0.54, valued at
$67.5k
|
|
| 06/13/2018 |
4
| Henderson Molly (Executive Vice President & CFO) has filed a Form 4 on Advaxis, Inc.|
Txns:
| Granted 5,000 shares
@ $1.89, valued at
$9.5k
|
|
| 06/08/2018 |
4
| Henderson Molly (Executive Vice President & CFO) has filed a Form 4 on Advaxis, Inc.|
Txns:
| Granted 250,000 options
@ $1.71, valued at
$427.5k
|
|
| 06/08/2018 |
3
| Henderson Molly (Executive Vice President & CFO) has filed a Form 3 on Advaxis, Inc. |
| 06/15/2016 |
4
| Henderson Molly (CFO) has filed a Form 4 on Lion Biotechnologies, Inc.|
Txns:
| Granted 150,000 options
@ $5.87, valued at
$880.5k
Granted 50,000 options
@ $7.61, valued at
$380.5k
|
|
| 03/15/2016 |
4
| Henderson Molly (CFO) has filed a Form 4 on Lion Biotechnologies, Inc.|
Txns:
| Granted 100,000 options to buy
@ $5.05, valued at
$505k
|
|
| 12/30/2015 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 06/10/2015 |
4
| Henderson Molly (CFO) has filed a Form 4 on Lion Biotechnologies, Inc.|
Txns:
| Granted 200,000 options
@ $10.69, valued at
$2.1M
|
|
| 02/11/2013 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 06/21/2012 |
4
| Henderson Molly (CBFO) has filed a Form 4 on VirtualScopics, Inc.|
Txns:
| Bought 8,000 shares
@ $0.9, valued at
$7.2k
|
|
| 01/30/2012 |
4
| Henderson Molly (Chief Business/Financial Off.) has filed a Form 4 on VirtualScopics, Inc.|
Txns:
| Exercised (out-of-the-money) 12,500 options
@ $1.13, valued at
$14.1k
|
|
|